Ha lo-En ed iyn es: P r obin g th e Electr on ic a n d Ster eoelectr on ic
Con tr ibu tion s to th e Ber gm a n Cycloa r om a tiza tion
Gary W. Plourde II, Philip M. Warner, Dennis A. Parrish, and Graham B. J ones*
Department of Chemistry, Northeastern University, Boston, Massachusetts 02115
gr.jones@neu.edu
Received March 26, 2002
A series of halogen-substituted cyclic enediynes were prepared with use of carbenoid coupling
strategy. DFT analysis, initially used to identify synthesis candidates, was also employed to
rationalize the propensity for cycloaromatization of the compounds. In all cases studied the halogen
atom had a strongly retardative effect on the thermal Bergman cycloaromatization reaction. The
isolation of the first C-9 monochloroenediyne is noteworthy, and may find application in prodrug
design.
Interest in the enediyne antibiotics stems from their
observed antitumoral activity, as exemplified by cali-
cheamicin and esperamicin, both of which have entered
clinical trials.1 The enediynes are not biologically active
per se, but undergo cycloaromatization of the enediyne
core to yield cytotoxic diyl radicals which subsequently
interact with macromolecule targets.2 In the case of cyclic
C-10 enediynes, this process is generally referred to as
the Bergman cycloaromatization, following the pioneering
discoveries made on related hex-3-en-1,5-diynes.3 The
naturally occurring enediynes all possess triggering
functions, which become activated in vitro to promote the
Bergman cycloaromatization.2,4 This typically involves a
conformational change in the architecture of the enediyne
such that on relief of strain, the alkyne termini adopt a
more favorable orientation for the cycloaromatization
event. In this manner, a strained enediyne that is
indefinitely stable at ambient temperature can be con-
verted to a species with a half-life of seconds. Accordingly,
much research has been conducted to exploit this method
of activation together with investigation of alternate
modes of triggering.4
Though strain relief plays a commanding role in the
cycloaromatization profiles of many natural and synthetic
enediynes,5 a variety of other factors can influence the
process, including subtle electronic effects. In the case
of synthetic C-10 enediyne cores, the electronic contribu-
tion to Bergman cyclization was first examined with
quinone enediyne 1.6 Bioreduction of the quinone to the
hydroquinone form serves to stabilize the enediyne
(1) Schor, N. F. In Cancer Therapeutics: Experimental and Clinical
Agents; Teicher, B., Ed.; Humana Press: Totowa, NJ , 1996; pp 229-
240. Schmitt, D. A.; Kisanuki, K.; Kimura, S.; Oka, K.; Pollard, R. B.;
Maeda, H.; Suzuki, F. Anticancer Res. 1992, 12, 2219. Takahashi, T.;
Yamaguchi, T.; Kitamura, K.; Noguchi, A.; Mitsuyo, H.; Otsuji, E. J pn.
J . Cancer Res. 1993, 84, 976. Lee, M. D.; Durr, F. E.; Hinman, L. H.;
Haman, P. R.; Ellestad, G. A. In Advances in Medicinal Chemistry;
Maryanoff, B. E., Maryanoff, C. A., Eds.; J ai Press: Greenwich, CT,
1993; Vol. 2.
(2) Xi, Z.; Goldberg, I. DNA damaging enediyne compounds. In
Comprehensive Natural Products Chemistry; Barton, D. H. R., Nakan-
ishi, K., Eds.; Pergamon: Oxford, UK, 1999; Vol. 7, p 553. Smith, A.
L.; Nicolaou, K. C. J . Med. Chem. 1996, 39, 2103. Grissom, J . W.;
Gunawardena, G. U.; Klingberg, D.; Huang, D. Tetrahedron 1996, 52,
6453.
(5) Magnus, P.; Fortt, S.; Pitterna, T.; Snyder, J . P. J . Am. Chem.
Soc. 1990, 112, 4986.
(3) Bergman, R. G. Acc. Chem. Res. 1973, 6, 25.
(4) Reviews of enediyne prodrugs: Maier, M. E. Synlett 1995, 13.
J ones, G. B.; Fouad, F. S. Curr. Pharm. Des. 2002, 8, in press.
(6) Nicolaou, K. C.; Smith, A. L.; Wendeborn, S. V.; Hwang, C. K.
J . Am. Chem. Soc. 1991, 113, 3106.
10.1021/jo025763e CCC: $22.00 © 2002 American Chemical Society
Published on Web 06/20/2002
J . Org. Chem. 2002, 67, 5369-5374
5369